Tag: prevention

The Endocrine Society has intensified its multi-front campaign to safeguard the future of biomedical research in the United States, targeting a controversial proposed rule by the Office of Management and Budget (OMB) that threatens to fundamentally alter the landscape of scientific funding. The proposed regulation, which has sparked widespread alarm across the scientific community, seeks…

In a decisive move aimed at addressing one of the most persistent financial burdens in the American healthcare system, the Senate Health, Education, Labor, and Pensions (HELP) Committee has officially passed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act. This bipartisan legislation represents a significant milestone in a years-long advocacy campaign…

The management of pheochromocytomas and paragangliomas (PPGLs) has long been one of the most complex challenges in clinical endocrinology and oncology. These rare neuroendocrine tumors, which arise from the adrenal medulla or the extra-adrenal sympathetic and parasympathetic paraganglia, possess a clinical unpredictability that often leaves physicians with more questions than answers. Because there are currently…

The National Institutes of Health (NIH) has officially announced a $21 million funding commitment to establish the Computational Modeling of Hormone Homeostasis Initiative, a landmark program designed to revolutionize how medical researchers understand the intricate interplay of human hormones. By prioritizing the development of advanced computer-based simulations, the initiative aims to bridge a long-standing gap…

The National Institutes of Health (NIH) has announced a significant $4.6 million initial award to a multi-institutional team led by Michigan State University (MSU), marking the commencement of a high-stakes project designed to revolutionize the development and prescription of medications for women. This funding represents the first installment of a potential $12.8 million grant spanning…

A comprehensive retrospective study presented at the ENDO 2026 annual meeting has revealed significant gaps in the diagnostic procedures preceding the prescription of testosterone therapy for men. Led by researchers from the University of Michigan, the study indicates that only a small fraction of patients receive the full battery of guideline-concordant testing required to ensure…

The Endocrine Society and Keystone Symposia have announced a landmark collaboration to launch a series of high-level scientific meetings designed to explore the complex intersections of hormone signaling, oncology, diabetes, and cardiometabolic health. This strategic partnership seeks to dismantle traditional academic silos, fostering an environment where experts from disparate fields can share insights and accelerate…

A comprehensive study published in the Journal of the Endocrine Society has established a significant correlation between exposure to phthalates—chemicals ubiquitous in modern consumer goods—and elevated blood pressure levels in pregnant women. This research, led by scientists at the Harvard T.H. Chan School of Public Health, underscores a growing public health concern regarding "everywhere chemicals"…

The annual ENDO conference, hosted by the Endocrine Society, serves as a global stage for the most significant advancements in hormone research and clinical endocrinology. At the ENDO 2026 meeting held in Chicago, Illinois, one of the most anticipated segments was the Rising Star Power Talks, a high-stakes research communication competition designed to highlight the…

The landscape of metabolic medicine and post-operative bariatric care has reached a significant turning point following the announcement of positive topline results from the Phase 3 LUCIDITY clinical trial. Amylyx Pharmaceuticals, Inc., a company primarily known for its focus on neurodegenerative diseases, has successfully demonstrated the efficacy and safety of avexitide, a first-in-class glucagon-like peptide-1…